Glyscend develops a gut-targeted polymer therapy that mimics the physiological effects of bariatric surgery through an oral pill, providing a non-invasive treatment option for type 2 diabetes and obesity. This approach offers patients the metabolic benefits of gastric bypass without the associated surgical risks.
Funding
$19.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Type 2 diabetes and obesity are significant health challenges, often requiring invasive procedures like bariatric surgery to achieve substantial metabolic improvements. These surgical interventions, while effective, carry inherent risks and are not suitable for all patients.
Solution
Glyscend Therapeutics develops orally administered, gut-targeted polymer therapies designed to replicate the physiological effects of bariatric surgery without the need for an invasive procedure. These polymer-based drugs create a dynamic barrier in the gut, mimicking the metabolic benefits of gastric bypass and duodenal exclusion. This approach offers a non-surgical option for managing type 2 diabetes and obesity by altering nutrient absorption and hormonal signaling in the gastrointestinal tract. The therapy aims to provide similar glycemic control and weight management benefits as surgery, but through a convenient, orally delivered pill.
Target Audience
The primary target audience includes individuals with type 2 diabetes, overweight individuals, and/or obese patients who are seeking a non-surgical alternative to achieve the metabolic benefits of bariatric surgery.
Features
- Orally administered polymer therapeutic that targets the gut
- Mimics the physiological effects of bariatric surgery, specifically gastric bypass and duodenal exclusion
- Non-invasive approach to managing type 2 diabetes and obesity
- Alters nutrient absorption and hormonal signaling in the GI tract
- Aims to provide similar glycemic control and weight management benefits as surgery